Applied DNA Sciences Inc (APDN)
3.75
-0.34
(-8.31%)
USD |
NASDAQ |
May 03, 16:00
3.785
+0.04
(+0.93%)
After-Hours: 20:00
Applied DNA Sciences Cash from Operations (Quarterly): -3.758M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.758M |
| September 30, 2023 | -2.680M |
| June 30, 2023 | -1.369M |
| March 31, 2023 | 0.2144M |
| December 31, 2022 | -2.383M |
| September 30, 2022 | -3.259M |
| June 30, 2022 | -1.754M |
| March 31, 2022 | -0.2619M |
| December 31, 2021 | -3.702M |
| September 30, 2021 | -4.712M |
| June 30, 2021 | -1.250M |
| March 31, 2021 | -3.270M |
| December 31, 2020 | -4.156M |
| September 30, 2020 | -2.983M |
| June 30, 2020 | -3.009M |
| March 31, 2020 | -2.420M |
| December 31, 2019 | -2.731M |
| September 30, 2019 | -1.777M |
| June 30, 2019 | -1.283M |
| March 31, 2019 | -2.288M |
| December 31, 2018 | -1.514M |
| September 30, 2018 | -2.509M |
| June 30, 2018 | -1.129M |
| March 31, 2018 | -0.707M |
| December 31, 2017 | -2.573M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.9139M |
| June 30, 2017 | -1.866M |
| March 31, 2017 | -2.630M |
| December 31, 2016 | -2.069M |
| September 30, 2016 | -2.446M |
| June 30, 2016 | -2.227M |
| March 31, 2016 | -2.503M |
| December 31, 2015 | -2.721M |
| September 30, 2015 | -1.739M |
| June 30, 2015 | -1.255M |
| March 31, 2015 | -1.616M |
| December 31, 2014 | -2.356M |
| September 30, 2014 | -2.242M |
| June 30, 2014 | -2.008M |
| March 31, 2014 | -2.196M |
| December 31, 2013 | -2.066M |
| September 30, 2013 | -2.173M |
| June 30, 2013 | -1.808M |
| March 31, 2013 | -2.149M |
| December 31, 2012 | -1.740M |
| September 30, 2012 | -0.9927M |
| June 30, 2012 | -1.124M |
| March 31, 2012 | -1.032M |
| December 31, 2011 | -0.8115M |
| September 30, 2011 | -1.561M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-4.712M
Minimum
Sep 2021
0.2144M
Maximum
Mar 2023
-2.450M
Average
-2.680M
Median
Sep 2023
Cash from Operations (Quarterly) Benchmarks
| Fonar Corp | 4.071M |
| XWELL Inc | -3.201M |
| ProPhase Labs Inc | -0.213M |
| Veracyte Inc | 15.55M |
| OncoCyte Corp | -4.562M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | -0.0351M |
| Free Cash Flow | -7.592M |
| Free Cash Flow Per Share (Quarterly) | -5.496 |
| Free Cash Flow to Equity (Quarterly) | -3.758M |
| Free Cash Flow to Firm (Quarterly) | -3.758M |
| Free Cash Flow Yield | -305.2% |